DE69626860D1 - Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert - Google Patents

Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert

Info

Publication number
DE69626860D1
DE69626860D1 DE69626860T DE69626860T DE69626860D1 DE 69626860 D1 DE69626860 D1 DE 69626860D1 DE 69626860 T DE69626860 T DE 69626860T DE 69626860 T DE69626860 T DE 69626860T DE 69626860 D1 DE69626860 D1 DE 69626860D1
Authority
DE
Germany
Prior art keywords
receptor
bond
test system
elisa test
substances inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626860T
Other languages
English (en)
Other versions
DE69626860T2 (de
Inventor
Manfred Auer
Franz Hammerschmid
Georg Stingl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69626860D1 publication Critical patent/DE69626860D1/de
Application granted granted Critical
Publication of DE69626860T2 publication Critical patent/DE69626860T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DE69626860T 1995-12-28 1996-12-23 Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert Expired - Fee Related DE69626860T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526599.7A GB9526599D0 (en) 1995-12-28 1995-12-28 Elisa test system
PCT/EP1996/005824 WO1997024617A1 (en) 1995-12-28 1996-12-23 Elisa test system

Publications (2)

Publication Number Publication Date
DE69626860D1 true DE69626860D1 (de) 2003-04-24
DE69626860T2 DE69626860T2 (de) 2003-12-04

Family

ID=10786124

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626860T Expired - Fee Related DE69626860T2 (de) 1995-12-28 1996-12-23 Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert

Country Status (12)

Country Link
US (1) US6258549B1 (de)
EP (1) EP0882229B1 (de)
JP (1) JP2000502793A (de)
AT (1) ATE235054T1 (de)
AU (1) AU1305897A (de)
CY (1) CY2470B1 (de)
DE (1) DE69626860T2 (de)
DK (1) DK0882229T3 (de)
ES (1) ES2195037T3 (de)
GB (1) GB9526599D0 (de)
PT (1) PT882229E (de)
WO (1) WO1997024617A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769954B2 (en) * 1996-11-26 2004-02-12 Heska Corporation Method to detect IgE
US5945294A (en) 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US7759133B2 (en) 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
WO2003015716A2 (en) * 2001-08-13 2003-02-27 Ige Therapeutics, Inc. Immunoglobulin e vaccines and methods of use thereof
US20060154372A1 (en) * 2004-12-21 2006-07-13 Arter Thomas C Providing additional motion in assays
US20080206855A1 (en) * 2005-05-06 2008-08-28 Kalypsys, Inc. Automated Compound Screening Using Gel-Permeation Matrix and Pin-Based Sample Transfer
US20110256641A1 (en) * 2010-04-19 2011-10-20 Michael Ling Methods and Systems for Detecting Free IgE
CN110358738B (zh) * 2019-08-22 2021-08-13 中国食品药品检定研究院 一种稳定测定抗IgE抗体药物生物学活性的方法
CN110716054A (zh) * 2019-09-11 2020-01-21 天津医科大学 一种血清亲细胞性免疫球蛋白e的定量检测试剂盒
CN110716055A (zh) * 2019-09-11 2020-01-21 天津医科大学 过敏原特异性免疫球蛋白e致病活性检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US4962035A (en) 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
US5639660A (en) 1988-02-24 1997-06-17 Hoffmann-La Roche Inc. Polypeptide and DNA sequence corresponding to the human receptor with high affinity for IgE
EP0507586A3 (en) 1991-04-03 1993-03-03 Syntex (U.S.A.) Inc. Immunoassay for immunoglobulins
DK137992D0 (da) 1992-11-13 1992-11-13 Alk Lab As Fremgangsmaade til paavisning af et immunologisk aktivt stof i en proeve under anvendelse af et maerkningsstof
JPH0772150A (ja) * 1993-09-02 1995-03-17 Tonen Corp ＩｇＥの測定方法
CA2176811C (en) 1993-12-10 2008-01-29 David Tai Wai Fei Methods for diagnosis of allergy and screening of anti-allergy therapeutics
AU3002695A (en) * 1994-07-08 1996-02-09 King's College Ige antagonists

Also Published As

Publication number Publication date
US6258549B1 (en) 2001-07-10
ATE235054T1 (de) 2003-04-15
ES2195037T3 (es) 2003-12-01
EP0882229A1 (de) 1998-12-09
CY2470B1 (en) 2005-06-03
DK0882229T3 (da) 2003-07-14
GB9526599D0 (en) 1996-02-28
WO1997024617A1 (en) 1997-07-10
PT882229E (pt) 2003-07-31
AU1305897A (en) 1997-07-28
JP2000502793A (ja) 2000-03-07
DE69626860T2 (de) 2003-12-04
EP0882229B1 (de) 2003-03-19

Similar Documents

Publication Publication Date Title
HUP0202532A2 (hu) Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
PT868519E (pt) Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2
ATE233813T1 (de) Veränderte immunglobuline für spezifische fc- epsilon rezeptoren
EP1361229A3 (de) Verwendung von Tyrosine Kinase (PYK2) zur Produktion von Antikörper
PL336635A1 (en) Proteins of human tool-like receptor and their associated reagents and methods
PT914345E (pt) Ligacao de anticorpos a receptores (ccr2) de proteina 1 de quimio-atraccao de monocitos (pqm-1)
ATE309349T1 (de) Chemokinrezeptor 88c sowie dessen antikörper
DE69626860T2 (de) Elisa testsystem zur bestimmung von substanzen, die die bindung zwischen ig e und dessen receptor inhibiert
DE69418284T2 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
DE69622978D1 (de) Analysator zur Analyse von Urinbestandteilen
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
DE69628847D1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
DE69728897D1 (de) Saeugetierchemokine
ES2148313T3 (es) Diagnostico precoz de la mucoviscidosis o de una mutacion del gen cftr.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ATE312914T1 (de) Rdgb-proteine
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
WO1996037610A3 (en) Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders
ATE184286T1 (de) Hgpiib-fragmente und ihre verwendung in in-vitro- verfahren zur bestimmung von in vivo stattfindenden thrombotischen ereignissen
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
WO2002078635A3 (en) Estrogen receptor modulators

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee